Insider · CIK 0002141966
Ilan Feuchtwang
Files at CTKB (Cytek Biosciences, Inc.). First filing -, latest -.
In brief
Ilan Feuchtwang files SEC Form 4 as officer at CTKB (Cytek Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ilan Feuchtwang has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | CTKB Cytek Biosciences, Inc. | AGrant or award Restricted Stock Unitsderivative | +241,416 | $0.00 | $0 | 241,416 | Aug 12, 2026 |
| Aug 10, 2026 | CTKB Cytek Biosciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +127,118 | $0.00 | $0 | 127,118 | Aug 12, 2026 |
Questions about Ilan Feuchtwang
Answered from the filings on this page, as of the latest one.
Is Ilan Feuchtwang buying or selling?
Ilan Feuchtwang has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ilan Feuchtwang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ilan Feuchtwang has 0.
Where does Ilan Feuchtwang file Form 4?
Ilan Feuchtwang has filed Form 4 at CTKB (Cytek Biosciences, Inc.) as Chief Legal Officer, Secretary. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.